retroworks writes: "The New York Times has an interesting article about the efforts by the Federal Drug Administration to locate a source of "leaks" within the agency... and how that became a slippery slope, involving trojans, keyloggers, screenshot captures, and an investigation that eventually becomes an allegory for management overkill. The article describes how the investigation of one employee expanded to five, and how the investigation of the five led to other staff (including intercept of correspondence to President Obama). Protecting trade secrets of drug companies which had applied for FDA approval, vs. censoring researchers with legitimate questions about the Agency's approval process, seems to be the grey area the Agency struggled with."